Who is sponsoring NCT03140280?

NCT03140280 is sponsored by Ehab L Atallah.

What condition does NCT03140280 study?

NCT03140280 studies Myelodysplastic Syndromes.

What drugs are being tested in NCT03140280?

Interventions: Freeze-Dried Black Raspberry Powder.

What is the status of NCT03140280?

NCT03140280 is currently COMPLETED.

Last reviewed 2022-11-04 · How we verify

Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)

NCT03140280 PHASE2 COMPLETED Results posted

This is a phase II, single-group pilot study to evaluate efficacy and methylation. This study's overarching aim is to evaluate the systemic effects of black raspberries in patients with myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm. Twenty-one patients with MDS will be treated with 25 gm (2x/day) of BRB powder taken orally.

Details

Lead sponsor	Ehab L Atallah
Phase	PHASE2
Status	COMPLETED
Enrolment	23
Start date	Mon Jun 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Myelodysplastic Syndromes

Interventions

Freeze-Dried Black Raspberry Powder

Countries

United States